[go: up one dir, main page]

SI1746097T1 - dihidropiridin kondenzirani heterocikli postopek za njihovo pripravo njihova uporaba in sestavki ki jih vsebujejo - Google Patents

dihidropiridin kondenzirani heterocikli postopek za njihovo pripravo njihova uporaba in sestavki ki jih vsebujejo

Info

Publication number
SI1746097T1
SI1746097T1 SI200530964T SI200530964T SI1746097T1 SI 1746097 T1 SI1746097 T1 SI 1746097T1 SI 200530964 T SI200530964 T SI 200530964T SI 200530964 T SI200530964 T SI 200530964T SI 1746097 T1 SI1746097 T1 SI 1746097T1
Authority
SI
Slovenia
Prior art keywords
dihydropyridine
preparing
same
compositions containing
fused heterocycles
Prior art date
Application number
SI200530964T
Other languages
English (en)
Inventor
Jacques Mauger
Anil Nair
Nina Ma
Kirsten Bjergarde
Bruno Filoche-Romme
Odile Angouillant-Boniface
Serge Mignani
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SI1746097T1 publication Critical patent/SI1746097T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SI200530964T 2005-07-20 2005-07-20 dihidropiridin kondenzirani heterocikli postopek za njihovo pripravo njihova uporaba in sestavki ki jih vsebujejo SI1746097T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05291558A EP1746097B1 (en) 2005-07-20 2005-07-20 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them

Publications (1)

Publication Number Publication Date
SI1746097T1 true SI1746097T1 (sl) 2010-05-31

Family

ID=35510894

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530964T SI1746097T1 (sl) 2005-07-20 2005-07-20 dihidropiridin kondenzirani heterocikli postopek za njihovo pripravo njihova uporaba in sestavki ki jih vsebujejo

Country Status (37)

Country Link
US (1) US8163768B2 (sl)
EP (2) EP1746097B1 (sl)
JP (2) JP2009501778A (sl)
KR (1) KR101286796B1 (sl)
CN (1) CN101243087B (sl)
AR (1) AR054845A1 (sl)
AT (2) ATE455115T1 (sl)
AU (1) AU2006273692B8 (sl)
BR (1) BRPI0614002A2 (sl)
CA (1) CA2615700C (sl)
CR (1) CR9663A (sl)
CY (1) CY1109964T1 (sl)
DE (1) DE602005018911D1 (sl)
DK (1) DK1746097T3 (sl)
DO (1) DOP2006000175A (sl)
EA (1) EA016815B1 (sl)
EC (1) ECSP078062A (sl)
ES (1) ES2339676T3 (sl)
HN (1) HN2008000088A (sl)
HR (1) HRP20100195T1 (sl)
IL (1) IL188861A0 (sl)
MA (1) MA29634B1 (sl)
MX (1) MX2008000902A (sl)
MY (1) MY148617A (sl)
NO (1) NO20080831L (sl)
NZ (1) NZ592766A (sl)
PE (2) PE20100718A1 (sl)
PL (1) PL1746097T3 (sl)
PT (1) PT1746097E (sl)
RS (1) RS51351B (sl)
SI (1) SI1746097T1 (sl)
TN (1) TNSN08020A1 (sl)
TW (1) TWI386411B (sl)
UA (1) UA98928C2 (sl)
UY (1) UY29685A1 (sl)
WO (1) WO2007012972A2 (sl)
ZA (1) ZA200800542B (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2945535B1 (fr) * 2009-05-18 2011-06-10 Sanofi Aventis Compose anticancereux et composition pharmaceutique le contenant
FR2967413A1 (fr) * 2010-11-17 2012-05-18 Sanofi Aventis Compose 8-oxo-9-[3-(1h-benzimidazol-2-yloxy)-phenyl]-4,5,6,7,8,9-hexahydro-2h-pyrrolo[3,4-b]quinoline-3-carboxylate d'ethyle, sel, forme cristalline, co-cristal, formulation, procedes de preparation, application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteur des kinases aurora.
AU2013261130A1 (en) 2012-05-15 2014-10-23 Novartis Ag Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
ES2670667T3 (es) 2012-05-15 2018-05-31 Novartis Ag Derivados de benzamida para inhibir la actividad de ABL1, ABL2 y BCR-ABL1
NZ701626A (en) 2012-05-15 2016-02-26 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
MX357305B (es) 2012-05-15 2018-07-04 Novartis Ag Compuestos y composiciones para inhibir la actividad de abl-1, abl-2, y bcr-abl1.
DK2909204T3 (en) 2012-10-12 2019-04-01 Broad Inst Inc GSK3 INHIBITORS AND METHODS FOR USE THEREOF
EP3230279A1 (en) 2014-12-10 2017-10-18 Massachusetts Institute of Technology Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
CA3241654A1 (en) 2015-04-30 2016-11-03 Memorial Sloan-Kettering Cancer Center Mitragynine analogs and uses thereof
RU2619932C1 (ru) * 2015-11-25 2017-05-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет" (ФГБОУ ВО "ВГУ") ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-а]ПИРИДО[3,4-е]ПИРИМИДИНЫ И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ПРОТЕИНКИНАЗ
US11180492B2 (en) 2016-01-15 2021-11-23 University Of Central Florida Research Foundation, Inc. Anti-parasitic compounds and uses thereof
CA3012846A1 (en) 2016-02-16 2017-08-24 Massachusetts Institute Of Technology Max binders as myc modulators and uses thereof
SG11201909115WA (en) 2017-04-05 2019-10-30 Broad Inst Inc Tricyclic compounds as glycogen synthase kinase 3 (gsk3) inhibitors and uses thereof
US11084781B2 (en) * 2017-05-12 2021-08-10 Research Triangle Institute Diarylureas as CB1 allosteric modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2314355A1 (en) * 1997-12-13 1999-06-24 Bristol-Myers Squibb Company Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors
MXPA02005016A (es) 1999-11-19 2003-01-28 Abbott Lab Abridores de canal de potasio de dihidropirimidina triciclica.
WO2001066544A2 (en) 2000-03-03 2001-09-13 Abbott Laboratories Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
US6538004B2 (en) 2000-03-03 2003-03-25 Abbott Laboratories Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
JP2005501800A (ja) 2001-02-02 2005-01-20 三菱ウェルファーマ株式会社 ジヒドロピラゾロピリジン化合物およびその医薬用途
FR2823854A1 (fr) * 2001-04-18 2002-10-25 Centre Nat Rech Scient Nouveau procede de criblage d'inhibiteurs de la liaison entre la proteine oxyde nitrique synthase neuronale et la proteine inhibitrice de l'oxyde nitrique synthase neuronale
FR2825091B1 (fr) * 2001-05-23 2003-07-04 Servier Lab Nouveaux derives tricycliques de dihydro-quinnoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7037902B2 (en) * 2002-07-03 2006-05-02 Receptron, Inc. Affinity small molecules for the EPO receptor
SE0301371D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab New Compounds
RU2006100484A (ru) * 2003-06-13 2006-06-10 Центарис ГмбХ, Германи (DE) Соединения, обладающие ингибирующей активностью в отношении фосфатидилинозит-3-киназы, фармацевтическая композиция, способ определения эффективности этих соединений, способ лечения нарушений (варианты) и способ изменения передачи сигнала в клетках

Also Published As

Publication number Publication date
JP2009501778A (ja) 2009-01-22
KR101286796B1 (ko) 2013-07-17
EA200800374A1 (ru) 2008-08-29
US20080261969A1 (en) 2008-10-23
US8163768B2 (en) 2012-04-24
AU2006273692A8 (en) 2012-12-13
UA98928C2 (ru) 2012-07-10
CA2615700C (en) 2013-06-18
MX2008000902A (es) 2008-03-26
DK1746097T3 (da) 2010-05-25
AU2006273692A1 (en) 2007-02-01
MA29634B1 (fr) 2008-07-01
BRPI0614002A2 (pt) 2011-03-01
DE602005018911D1 (de) 2010-03-04
EP1910366A2 (en) 2008-04-16
TW200740812A (en) 2007-11-01
NZ592766A (en) 2012-12-21
CN101243087B (zh) 2013-07-24
HN2008000088A (es) 2011-05-31
IL188861A0 (en) 2008-04-13
ECSP078062A (es) 2008-01-23
EP1910366B1 (en) 2011-08-24
ES2339676T3 (es) 2010-05-24
CN101243087A (zh) 2008-08-13
PE20100718A1 (es) 2010-10-20
CY1109964T1 (el) 2014-09-10
CR9663A (es) 2008-02-21
EA016815B1 (ru) 2012-07-30
PE20070212A1 (es) 2007-03-21
MY148617A (en) 2013-05-15
AU2006273692B2 (en) 2012-11-22
EP1746097A1 (en) 2007-01-24
ATE455115T1 (de) 2010-01-15
KR20080026658A (ko) 2008-03-25
HRP20100195T1 (hr) 2010-05-31
UY29685A1 (es) 2007-02-28
AR054845A1 (es) 2007-07-18
AU2006273692B8 (en) 2012-12-13
EP1746097B1 (en) 2010-01-13
PL1746097T3 (pl) 2010-06-30
RS51351B (sr) 2011-02-28
CA2615700A1 (en) 2007-02-01
DOP2006000175A (es) 2007-03-31
JP2013063987A (ja) 2013-04-11
TWI386411B (zh) 2013-02-21
WO2007012972A3 (en) 2007-04-05
PT1746097E (pt) 2010-04-15
ZA200800542B (en) 2010-02-24
WO2007012972A2 (en) 2007-02-01
TNSN08020A1 (en) 2009-07-14
NO20080831L (no) 2008-04-03
ATE521611T1 (de) 2011-09-15

Similar Documents

Publication Publication Date Title
IL188861A0 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
IL184524A0 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
ZA200709856B (en) Fluorene derivatives,compositions containing said derivatives and the use thereof
IL225207A (en) A derivative of multi-ring carbamoylpyridone, its pharmaceutical composition, its use and its preparation
IL214183A (en) Pharma-informatics system and method, preparation for use with it and method for preparation of the preparation
IL195580A (en) L – fkbp polypeptides, preparations containing them, methods of preparation and use
ZA200710108B (en) Layered composition and processes for preparing and using the composition
ZA200710360B (en) Novel 1,4-benzothiazepine-1, 1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
ZA200704865B (en) Layered composition and processes for preparing and using the composition
IL187235A0 (en) 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
IL175300A0 (en) Indirubin-type compounds, compositions, and methods for their use
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
IL176420A0 (en) Process for the manufacture of 2,3-dichloropyridine
PL394600A1 (pl) Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
IL180397A0 (en) Diamine derivatives, fungicidal compositions containing the same, and processes for the preparation thereof
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
IL184488A0 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
PL1783105T3 (pl) Kompozycja zaprawowa, sposób jej wytwarzania i jej zastosowanie
IL191560A0 (en) 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same
IL187673A0 (en) Process for preparing 3,3-diarylpropylamines
GB0305089D0 (en) Composition, use and process
IL195148A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof and compositions containing the same
IL183438A0 (en) Substituted indoles, compositions containing them, method for the production thereof and their use